Description: Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty; and Urofollitropin for injection to treat anovulation and sufferers. It also provides Perospirone hydrochloride tablets to treat schizophrenia; Shenqi Fuzheng Injection to treat weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for treating lung and stomach cancer; anti-viral granules used for clearing heat, eliminating dampness, cooling blood, and detoxifying to treat upper respiratory tract infection and influenza; Tocilizumab injection to treat rheumatoid arthritis; and Recombinant SARSCoV-2 fusion protein vaccine used to prevent diseases caused by SARS-CoV-2 infection. In addition, the company offers antinuclear antibody test kit, used for the detection of common anti-nuclear and anti-antibodies in the autoimmune diseases; nucleic acid test kits for human immunodeficiency virus type 1; interferon-gamma release assays test kits, used to determine whether the human body is infected with Mycobacterium tuberculosis; diagnostic kit for IgM antibody to mycoplasma pneumonia. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.
Home Page: www.livzon.com.cn
Headquarters Building
Zhuhai,
519090
China
Phone:
86 75 6813 5888
Officers
Name | Title |
---|---|
Mr. Yanggang Tang | President & Executive Director |
Mr. Guoxiang Xu | Executive Vice Chairman & VP of Sales |
Ms. Yanxia Si | VP & CFO |
Mr. Liang Yang | VP, Secretary to the Board & Company Secretary |
Mr. Daihong Yang | Vice President |
Ms. Yuxuan Huang | Vice President |
Mr. Jun Du | Vice President |
Jianing Liu | Chief Investment Officer & Head of BD Dept. |
Ms. Jianying Zhuang | Head of Accounting Department |
Mr. Maolin Wang | Chief Supervisor and GM of Legal & Compliance |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 10.8966 |
Price-to-Book MRQ: | 1.5916 |
Price-to-Sales TTM: | 0.3414 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 8933 |